CTLA-4 Blockade Resistance after Relatlimab and Nivolumab
Alexander M. Menzies, Ines Pires da Silva, Claudia Trojaniello, Elisabeth Vieu, Rodabe N. Amaria, Lisa Zimmer, Serigne N. Lo, Elizabeth M. Burton, Hussein A. Tawbi, Dirk Schadendorf, Jean J. Grob, Paolo A. Ascierto, Georgina V. Long
Abstract
kein CA
Topics & Concepts
NivolumabMedicineBlockadeCancer researchImmunotherapyInternal medicinePharmacologyPD-L1Drug resistanceAntibodyOncologyAcquired resistanceCancerImmune checkpointImmune systemCancer Immunotherapy and BiomarkersT-cell and B-cell ImmunologyMelanoma and MAPK Pathways